Text Size

Diquafosol ophthalmic solution for dry eye treatment

Nakamura M., Imanaka T., Sakamoto A.


  • 2012
  • Advances in Therapy
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology

    Pharmacology

  • Categories

    Clinical development

  • Affiliations

    Research and Development Division, Santen Pharmaceutical Co., Ltd, 8916-16, Takayama-cho, Ikoma-shi, Nara 630-0101., Japan; Research and Development Division, Santen Pharmaceutical Co., Ltd., 3-9-19, Shimoshinjo, Higashiyodogawa-ku, Osaka 533-8651, Japan

Related Publications

Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.


Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.


Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022